comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 04:50:47 - browse：372

Micrograph of ulcerative colitis -- biotech coverage from STAT — Micrograph of chronic active ulcerative colitis in a biopsy specimen. Wikimedia Commons

Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers. AltruBio, a Bay Area biotech, is betting it can help patients suffering from autoimmune and inflammatory diseases by taking the opposite tack: pumping the brakes on runaway immune responses.

The company on Tuesday announced that it has raised $225 million in a Series B venture round led by BVP Partners, with the biotech’s backers also including RA Capital Management, Cormorant Asset Management, and Soleus Capital. AltruBio plans to put that money toward advancing a drug that is already being tested in a mid-stage trial for ulcerative colitis, an increasingly competitive market in which a number of pharma companies have launched drugs.

It’s the latest example of intense investor interest in immunology-focused companies. Firms such as Paragon Therapeutics and Prometheus Laboratories have recently been at the center of financing mega-rounds, and Blackstone Life Sciences recently committed up to $300 million to launch Uniquity Bio, a company developing treatments for asthma and chronic obstructive pulmonary disease.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA seeking to stop procedures at two unregulated stem cell clinics

explore

WSS

Princess Kate attends Wimbledon with Roger Federer: See the photos

Biden administration sends mixed signals on US soldier who crossed into North Korea

Princess Kate attends Wimbledon with Roger Federer: See the photos

Princess Kate attends Wimbledon with Roger Federer: See the photos

5 shark bites reported on Long Island as officials deploy surveillance drones

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

In Memoriam: Notable people who died in 2023

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Heart attack and stroke risk calculators need revising

Biden administration sends mixed signals on US soldier who crossed into North Korea

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Sports medicine is finally prioritizing gender equality

Manchin plays down potential 3rd

Hollywood unions extend contract negotiations for actors

Former New York Mayor de Blasio and wife announce separation, but not divorce

entertainment

ER docs worry over extreme heat as a 'mass casualty event'

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Former New York Mayor de Blasio and wife announce separation, but not divorce

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Biden administration sends mixed signals on US soldier who crossed into North Korea

Biden administration sends mixed signals on US soldier who crossed into North Korea

explore

leisure time

hotspot

entertainment